316 related articles for article (PubMed ID: 11174464)
1. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
Orford JL; Kinlay S; Fernandes J; Behrendt D; Ganz P; Selwyn AP
J Lab Clin Med; 2001 Feb; 137(2):82-92. PubMed ID: 11174464
[No Abstract] [Full Text] [Related]
2. Insulin resistance.
Leiter L
Can J Cardiol; 1999 Apr; 15 Suppl B():20B-22B. PubMed ID: 10350679
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management.
Yudkin JS
J Diabetes Complications; 1996; 10(3):129-32. PubMed ID: 8807456
[No Abstract] [Full Text] [Related]
4. The proinflammatory and hypercoagulable state of diabetes mellitus.
Aras R; Sowers JR; Arora R
Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, hyperglycaemia, hyperinsulinaemia and atherosclerosis: epidemiological data.
Fontbonne A; Eschwege E
Diabete Metab; 1987 Jul; 13(3 Pt 2):350-3. PubMed ID: 3308563
[TBL] [Abstract][Full Text] [Related]
6. [Identification and prevention of vascular risk. Significance of metformin].
Isnard F; André P
Journ Annu Diabetol Hotel Dieu; 1990; ():311-23. PubMed ID: 2195214
[No Abstract] [Full Text] [Related]
7. [Diabetic cardiopathy].
Mattioli G
Cardiologia; 1995 Aug; 40(8):535-9. PubMed ID: 8536280
[No Abstract] [Full Text] [Related]
8. [Diabetic macroangiopathy--therapy and prevention].
Oikawa S
Nihon Rinsho; 2002 Sep; 60 Suppl 9():146-50. PubMed ID: 12386986
[No Abstract] [Full Text] [Related]
9. [Diabetes mellitus and coronary arteriosclerosis].
Slavina LS
Probl Endokrinol (Mosk); 1976; 22(5):100-9. PubMed ID: 799297
[No Abstract] [Full Text] [Related]
10. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease.
Ragucci E; Zonszein J; Frishman WH
Heart Dis; 2003; 5(1):18-33. PubMed ID: 12549986
[TBL] [Abstract][Full Text] [Related]
12. [Chronic inflammation can cause type 2 diabetes].
Sjöholm A; Nyström T
Lakartidningen; 2004 May; 101(19):1716-21. PubMed ID: 15188586
[No Abstract] [Full Text] [Related]
13. [The treatment of diabetic dyslipidemia].
Rubinstein A; Izhakov E
Harefuah; 2001 Aug; 140(8):744-6. PubMed ID: 11547480
[No Abstract] [Full Text] [Related]
14. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
Candido R; Zanetti M
Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the deadly quartet.
Deedwania PC
Can J Cardiol; 2000 Aug; 16 Suppl E():17E-20E. PubMed ID: 10906620
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents.
Dandona P; Aljada A
J Diabetes Complications; 2004; 18(2):91-102. PubMed ID: 15120703
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of coronary cardiopathy in 416 diabetic patients treated with insulin or oral hypoglycemic agents].
Comi D; Santagostino A; Ragaini S; Baroni GC; Porro T; Pagani G
Boll Soc Ital Cardiol; 1975; 20(1):73-80. PubMed ID: 1231897
[No Abstract] [Full Text] [Related]
18. The importance of diabetes as a cardiovascular risk factor.
Plouin PF
Int J Clin Pract Suppl; 2000 May; (110):3-8. PubMed ID: 10912301
[No Abstract] [Full Text] [Related]
19. Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria: rationale and effect on late-diabetic complications.
Gaede PH
Dan Med Bull; 2006 Aug; 53(3):258-84. PubMed ID: 17092449
[No Abstract] [Full Text] [Related]
20. [Mechanism of diabetic macroangiopathy].
Nishio Y
Nihon Rinsho; 2006 Nov; 64(11):1991-7. PubMed ID: 17087288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
